Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?
- PMID: 1587406
- DOI: 10.1016/0016-5085(92)90308-l
Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?
Abstract
In a 15-year surveillance program for long-standing, total ulcerative colitis (UC), 72 patients were followed up with colonoscopic biopsies. Seventeen patients developed definite dysplasia, carcinoma, and/or DNA aneuploidy. Alkaline phosphatase and transaminases were examined in all patients. In the group with dysplasia, carcinoma, and/or DNA aneuploidy, 5 patients (28%) were found to have primary sclerosing cholangitis (PSC) based on histological and/or cholangiographic criteria. In the group without definite dysplasia or DNA aneuploidy, no patient with PSC appeared, although two patients with other forms of chronic liver disorders were found. The difference in distribution of PSC between the two groups was statistically significant (P = 0.0004). Using logistic regression, the presence of PSC and the duration of UC were identified as independent risk factors associated with dysplasia and/or DNA aneuploidy. Thus, UC patients with PSC seem to run an increased risk of developing colonic dysplasia and/or DNA aneuploidy. Although the reason for the increased risk is still unclear, these results warrant increased surveillance among patients with both PSC and longstanding, total UC.
Comment in
-
Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis.Gastroenterology. 1992 Nov;103(5):1707-9. doi: 10.1016/0016-5085(92)91211-l. Gastroenterology. 1992. PMID: 1290531 No abstract available.
-
Primary sclerosing cholangitis and ulcerative colitis: potential cofactors in the dysplasia sequence.Gastroenterology. 1992 Jun;102(6):2161-2. doi: 10.1016/0016-5085(92)90349-4. Gastroenterology. 1992. PMID: 1587440 No abstract available.
Similar articles
-
Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.Hepatology. 1995 Nov;22(5):1404-8. doi: 10.1002/hep.1840220511. Hepatology. 1995. PMID: 7590655
-
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.Gastroenterology. 1996 Feb;110(2):331-8. doi: 10.1053/gast.1996.v110.pm8566577. Gastroenterology. 1996. PMID: 8566577
-
Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.Dis Colon Rectum. 2001 Jan;44(1):77-85. doi: 10.1007/BF02234825. Dis Colon Rectum. 2001. PMID: 11805567
-
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.Eur J Gastroenterol Hepatol. 2016 Apr;28(4):383-90. doi: 10.1097/MEG.0000000000000576. Eur J Gastroenterol Hepatol. 2016. PMID: 26938805 Review.
-
Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?Gut. 2001 Mar;48(3):430-4. doi: 10.1136/gut.48.3.430. Gut. 2001. PMID: 11171838 Free PMC article. Review. No abstract available.
Cited by
-
Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis.Int J Mol Sci. 2022 Apr 28;23(9):4905. doi: 10.3390/ijms23094905. Int J Mol Sci. 2022. PMID: 35563301 Free PMC article.
-
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.World J Gastroenterol. 2014 Jul 21;20(27):8783-9. doi: 10.3748/wjg.v20.i27.8783. World J Gastroenterol. 2014. PMID: 25083052 Free PMC article. Review.
-
Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature.Int J Colorectal Dis. 2014 Nov;29(11):1313-20. doi: 10.1007/s00384-014-1945-4. Epub 2014 Jul 4. Int J Colorectal Dis. 2014. PMID: 24990353 Review.
-
Cellular Mechanisms of Liver Fibrosis.Front Pharmacol. 2021 May 6;12:671640. doi: 10.3389/fphar.2021.671640. eCollection 2021. Front Pharmacol. 2021. PMID: 34025430 Free PMC article. Review.
-
Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis.Indian J Gastroenterol. 2012 Apr;31(2):69-74. doi: 10.1007/s12664-012-0175-3. Epub 2012 Apr 14. Indian J Gastroenterol. 2012. PMID: 22528343
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical